Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9644015 | 0.85 | L3MBTL1 (0.38) | L3MBTL1MAPK1ALDH1A1TP53CYP3A4 | |
| SCHEMBL9644012 | 0.84 | L3MBTL1 (0.38) | L3MBTL1MAPK1ALDH1A1TP53CYP3A4 | |
| SCHEMBL9798155 | 0.83 | HTT (0.33) | — | |
| SCHEMBL12891091 | 0.83 | L3MBTL1 (0.35) | L3MBTL1MAPK1LMNAPOLB | |
| SCHEMBL1323996 | 0.82 | NLRP3 (0.41) | L3MBTL1MAPK1ALDH1A1TP53CYP3A4 | |
| SCHEMBL16901532 | 0.82 | L3MBTL1 (0.37) | L3MBTL1MAPK1ALDH1A1TP53CYP3A4 | |
| SCHEMBL21301194 | 0.82 | LMNA (0.44) | L3MBTL1ALDH1A1LMNAPOLB | |
| SCHEMBL14783541 | 0.82 | L3MBTL1 (0.37) | L3MBTL1MAPK1ALDH1A1TP53CYP3A4 | |
| SCHEMBL15356646 | 0.81 | MGLL (0.37) | L3MBTL1MAPK1LMNAPOLB | |
| SCHEMBL13217160 | 0.81 | LMNA (0.50) | ALDH1A1LMNAPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4635941-A1 | PROCESS FOR PREPARING A PEROXYESTER OR PEROXYCARBONATE | Nouryon Chemicals International B.V. (NL) | 2025-10-22 | — | — | EP | claimed |
| EP-4471010-B1 | PROCESS FOR PREPARING A PEROXYESTER OR PEROXYCARBONATE | NOURYON CHEMICALS INT BV (NL) | 2025-06-04 | — | — | EP | claimed |
| US-20240400490-A1 | PROCESS FOR PREPARING A PEROXYESTER OR PEROXYCARBONATE | NOURYON CHEMICALS INTERNATIONAL B.V. (NL) | 2024-12-05 | — | — | US | claimed |
| EP-4471010-A1 | PROCESS FOR PREPARING A PEROXYESTER OR PEROXYCARBONATE | Nouryon Chemicals International B.V. (NL) | 2024-12-04 | — | — | EP | claimed |
| CN-117393857-B | Electrolyte combination, secondary electrolyte injection method for battery and battery | 天津力神电池股份有限公司 | 2024-04-19 | — | — | CN | claimed |
| CN-117393857-A | Electrolyte combination, secondary electrolyte injection method for battery and battery | 天津力神电池股份有限公司 | 2024-01-12 | — | — | CN | claimed |
| EP-4635941-A1 | PROCESS FOR PREPARING A PEROXYESTER OR PEROXYCARBONATE | Nouryon Chemicals International B.V. (NL) | 2025-10-22 | — | — | EP | disclosed |
| EP-4471010-B1 | PROCESS FOR PREPARING A PEROXYESTER OR PEROXYCARBONATE | NOURYON CHEMICALS INT BV (NL) | 2025-06-04 | — | — | EP | disclosed |
| US-20240400490-A1 | PROCESS FOR PREPARING A PEROXYESTER OR PEROXYCARBONATE | NOURYON CHEMICALS INTERNATIONAL B.V. (NL) | 2024-12-05 | — | — | US | disclosed |
| EP-4471010-A1 | PROCESS FOR PREPARING A PEROXYESTER OR PEROXYCARBONATE | Nouryon Chemicals International B.V. (NL) | 2024-12-04 | — | — | EP | disclosed |
| CN-117393857-B | Electrolyte combination, secondary electrolyte injection method for battery and battery | 天津力神电池股份有限公司 | 2024-04-19 | — | — | CN | disclosed |
| CN-117393857-A | Electrolyte combination, secondary electrolyte injection method for battery and battery | 天津力神电池股份有限公司 | 2024-01-12 | — | — | CN | disclosed |
| US-20200157053-A1 | Method of Treating or Inhibiting Malaria | UNIV OREGON HEALTH & SCIENCE (US) | 2020-05-21 | — | — | US | disclosed |
| US-6482970-B1 | Peroxides, their preparation process and use | AKZO NOBEL NV (NL) | 2002-11-19 | — | — | US | disclosed |
| EP-1071662-A1 | PEROXIDES, THEIR PREPARATION PROCESS AND USE | Akzo Nobel N.V. (NL) | 2001-01-31 | — | — | EP | disclosed |
| EP-1049668-A1 | KETONE PEROXIDE DERIVATIVES, THEIR PREPARATION AND USE | Akzo Nobel N.V. (NL) | 2000-11-08 | — | — | EP | disclosed |
| US-5972313-A | TOPICALLY APPLICABLE COSMETIC/DERMATOLOGICAL COMPOSITIONS FOR ARTIFICIALLY TANNING OR BROWNING HUMAN SKIN AND APPROPRIATELY PACKAGED, COMPRISE AT LEAST ONE DIHYDROXYACETONE (DHA) DERIVATIVE | SOCIETE L'OREAL S.A. (FR) | 1999-10-26 | — | — | US | disclosed |
| WO-1999052864-A1 | PEROXIDES, THEIR PREPARATION PROCESS AND USE | AKZO NOBEL N.V. (NL) | 1999-10-21 | — | — | WO | disclosed |
| WO-1999032442-A1 | KETONE PEROXIDE DERIVATIVES, THEIR PREPARATION AND USE | AKZO NOBEL N.V. (NL) | 1999-07-01 | — | — | WO | disclosed |
| US-5047261-A | Monoacrylated Alkylene Dicarbonate | SOCIETE NATIONALE DES POURDRES ET EXPLOSIFS (FR) | 1991-09-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240400490-A1 | PROCESS FOR PREPARING A PEROXYESTER OR PEROXYCARBONATE | GPX4, PRDX4, PRDX2 | L3MBTL1 4305/4885MAPK1 1339/4885ALDH1A1 327/4885 |
| US-20200157053-A1 | Method of Treating or Inhibiting Malaria | ELANE, ELF3, ELOB | L3MBTL1 1287/4885MAPK1 4570/4885ALDH1A1 2432/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.